Evidence map›Paper›PMID 35278369›Full record

ArticleCell stem cell2022

Lamin B1 deletion in myeloid neoplasms causes nuclear anomaly and altered hematopoietic stem cell function.

Andreea Reilly, J Philip Creamer, Sintra Stewart, Massiel C Stolla, Yuchuan Wang, Jing Du, Rachel Wellington, Stephanie Busch, Elihu H Estey, Pamela S Becker and 7 more

Open access · greenAbstract read
In one paragraph

Article in Cell stem cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. The synergistic effect of c-Myb hyperactivation and Pu.1 deficiency induces Pelger-Huët anomaly and promotes sAML.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Andreea ReillyDivision of Hematology, Department of Medicine, University of Washington, Seattle, WA 98195, USA.
J Philip CreamerDivision of Hematology, Department of Medicine, University of Washington, Seattle, WA 98195, USA.
Sintra StewartDivision of Hematology, Department of Medicine, University of Washington, Seattle, WA 98195, USA.
Massiel C StollaDivision of Hematology, Department of Medicine, University of Washington, Seattle, WA 98195, USA.
Yuchuan WangComputational Biology Department, Carnegie Mellon University, Pittsburgh, PA 15213, USA.
Jing DuDivision of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA.
Rachel WellingtonDivision of Hematology, Department of Medicine, University of Washington, Seattle, WA 98195, USA; Molecular and Cellular Biology Program, University of Washington, Seattle, WA 98195, USA.
Stephanie BuschDivision of Hematology, Department of Medicine, University of Washington, Seattle, WA 98195, USA.
Elihu H EsteyDivision of Hematology, Department of Medicine, University of Washington, Seattle, WA 98195, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Pamela S BeckerDivision of Hematology, Department of Medicine, University of Washington, Seattle, WA 98195, USA; Division of Hematology/Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, CA 92617, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Min FangDepartment of Clinical Transplant Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Siobán B KeelDivision of Hematology, Department of Medicine, University of Washington, Seattle, WA 98195, USA.
Janis L AbkowitzDivision of Hematology, Department of Medicine, University of Washington, Seattle, WA 98195, USA; Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Lorinda A SomaDivision of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA.
Jian MaComputational Biology Department, Carnegie Mellon University, Pittsburgh, PA 15213, USA.
Zhijun DuanDivision of Hematology, Department of Medicine, University of Washington, Seattle, WA 98195, USA; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98195, USA.
Sergei DoulatovDivision of Hematology, Department of Medicine, University of Washington, Seattle, WA 98195, USA; Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98195, USA. Electronic address: doulatov@uw.edu.
University of Washington · USCarnegie Mellon University · USFred Hutch Cancer Center · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
RESEARCH TRAINING IN HEMATOLOGYT32HL007093 · NHLBI · UNIVERSITY OF WASHINGTON · PI Janis L Abkowitz · 1985 to 2026
$13.9M
Physiology of feline leukemia virus C receptor, FLVCRR01HL031823 · NHLBI · UNIVERSITY OF WASHINGTON · PI ABKOWITZ, JANIS L · 1985 to 2024
$9.1M
Functional and molecular consequences of SF3B1 mutations in human hematopoietic stem cellsR01HL151651 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Robert K Bradley, Sergei Doulatov · 2020 to 2026
$4.0M
Uncovering epigenetic barriers to hematopoietic stem cell formationDP2HL147126 · NHLBI · UNIVERSITY OF WASHINGTON · PI DOULATOV, SERGEI · 2018 to 2018
$2.3M
Autologous red blood cells for transfusion in sickle cell diseaseR21HL139864 · NHLBI · UNIVERSITY OF WASHINGTON · PI DOULATOV, SERGEI · 2018 to 2019
$414k
NCI NIH HHS P30 CA015704NHLBI NIH HHS DP2 HL147126NHLBI NIH HHS R01 HL031823NHLBI NIH HHS R01 HL151651NHLBI NIH HHS R21 HL139864NHLBI NIH HHS T32 HL007093
6 · The paper itself

Abstract

Abnormal nuclear morphology is a hallmark of malignant cells widely used in cancer diagnosis. Pelger-Huët anomaly (PHA) is a common abnormality of neutrophil nuclear morphology of unknown molecular etiology in myeloid neoplasms (MNs). We show that loss of nuclear lamin B1 (LMNB1) encoded on chromosome 5q, which is frequently deleted in MNs, induces defects in nuclear morphology and human hematopoietic stem cell (HSC) function associated with malignancy. LMNB1 deficiency alters genome organization inducing in vitro and in vivo expansion of HSCs, myeloid-biased differentiation with impaired lymphoid commitment, and genome instability due to defective DNA damage repair. Nuclear dysmorphology of neutrophils in patients with MNs is associated with 5q deletions spanning the LMNB1 locus, and lamin B1 loss is both necessary and sufficient to cause PHA in normal and 5q-deleted neutrophils. LMNB1 loss thus causes acquired PHA and links abnormal nuclear morphology with HSCs and progenitor cell fate determination via genome organization.

Indexed as

Myeloproliferative DisordersNeoplasmsPelger-Huet AnomalyCell NucleusHematopoietic Stem CellsHumansLamin Type BLamin Type B3D genome5q deletionsgenome instabilityhematopoietic stem and progenitor cellslineage determinationmyeloid neoplasmsneutrophilsnuclear laminsnuclear morphology

Identifiers

PMID35278369
PMCPMC9018112
OpenAlexW4220982881

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.